NASDAQ: INAB
In8bio Inc Stock Ownership - Who owns In8bio?

Insider buying vs selling

Have In8bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter C. BrandtDirector2025-04-3081,967$0.18
$15.08kBuy
Peter C. BrandtDirector2025-04-3081,967$0.18
$15.08kBuy
Patrick McCallCHIEF FINANCIAL OFFICER2025-04-3015,000$0.18
$2.76kBuy
Kate RochlinChief Operating Officer2025-04-3012,295$0.18
$2.26kBuy
Alan S. RoemerDirector2025-04-30102,459$0.18
$18.85kBuy
Alan S. RoemerDirector2025-04-3011,000$0.18
$2.02kBuy

1 of 1

INAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INAB insiders and whales buy or sell their stock.

INAB Shareholders

What type of owners hold In8bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher10.57%9,597,434$1.51MInsider
Leslie W. Kreis10.57%9,597,434$1.51MInsider
Bios Capital Management LP9.47%8,600,001$1.35MInstitution
Aigh Capital Management LLC6.82%6,191,865$972.12kInstitution
Franklin Resources Inc6.28%5,696,202$894.30kInstitution
Alyeska Investment Group LP5.58%5,063,291$794.94kInstitution
William Taiwei Ho2.93%2,657,594$417.24kInsider
Vanguard Group Inc1.57%1,423,897$223.55kInstitution
Sigma Planning Corp1.15%1,041,380$163.50kInstitution
Peter C. Brandt0.87%786,828$123.53kInsider

1 of 3

INAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INAB33.08%25.77%Net BuyingNet Buying
IPA5.81%0.00%
MBRX3.32%38.32%Net Selling
ALLR0.69%13.17%Net Buying
BOLT48.32%51.68%Net Buying

In8bio Stock Ownership FAQ

Who owns In8bio?

In8bio (NASDAQ: INAB) is owned by 33.08% institutional shareholders, 25.77% In8bio insiders, and 41.15% retail investors. Aaron Gl Fletcher is the largest individual In8bio shareholder, owning 9.60M shares representing 10.57% of the company. Aaron Gl Fletcher's In8bio shares are currently valued at $1.56M.

If you're new to stock investing, here's how to buy In8bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.